FEED TEST


feed should appear below....

Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
2023-11-30

Xenon Pharmaceuticals Announces Proposed Public Offering
2023-11-29

Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
2023-11-27

Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
2023-11-09

SECOND FEED